Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$328K Sell
2,247
-6
-0.3% -$872 0.06% 405
2026
Q2
$327K Buy
2,253
+124
+6% +$15.4K 0.06% 434
2026
Q1
$226K Sell
2,129
-959
-31% -$109K 0.05% 552
2025
Q4
$328K Buy
+3,088
New +$312K 0.08% 293

Other funds holding ACA

Abel Hall LLC's ACA Position: Q3 2026 in Review

Abel Hall LLC reduced its Arcosa (ACA) stake by 0.27% in Q3 2026, selling an estimated $872 and leaving 2,247 shares worth $328K. The position accounts for 0.06% of the portfolio, ranked #405.

Abel Hall LLC first reported a position in ACA in Q4 2025 and has held it in 4 quarters since. 88 funds tracked by Wall St. Rank hold ACA as of Q3 2026.

  • Abel Hall LLC held 2,247 shares of Arcosa worth $328K as of Q3 2026.
  • Abel Hall LLC sold 6 Arcosa shares in Q3 2026, an estimated $872.
  • Arcosa made up 0.06% of Abel Hall LLC's portfolio in Q3 2026, its #405 holding.
  • Abel Hall LLC first reported a position in Arcosa in Q4 2025 and has held it in 4 quarters since.
  • 88 funds tracked by Wall St. Rank held Arcosa as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.